Loading...

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours

Tumours defective in the DNA homologous recombination repair pathway can be effectively treated with poly (ADP-ribose) polymerase (PARP) inhibitors; these have proven effective in clinical trials in patients with BRCA gene function-defective cancers. However, resistance observed in both pre-clinical...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Ordonez, Liliana D., Hay, Trevor, McEwen, Robert, Polanska, Urszula M., Hughes, Adina, Delpuech, Oona, Cadogan, Elaine, Powell, Steve, Dry, Jonathan, Tornillo, Giusy, Silcock, Lucy, Leo, Elisabetta, O’Connor, Mark J., Clarke, Alan R., Smalley, Matthew J.
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6498996/
https://ncbi.nlm.nih.gov/pubmed/31080552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26830
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!